Insider Transactions in Q2 2025 at Vaxcyte, Inc. (PCVX)
Insider Transaction List (Q2 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Apr 08
2025
|
Heath Lukatch Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+18.94%
|
$126,000
$18.75 P/Share
|
Apr 07
2025
|
Andrew Guggenhime PRESIDENT AND CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,777
+3.49%
|
$95,540
$20.93 P/Share
|
Apr 04
2025
|
Grant Pickering CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
20,533
+1.94%
|
$266,929
$13.14 P/Share
|